Clinical, laboratory, and radiographic aspects of patients with pulmonary tuberculosis and dysglycemia and tuberculosis treatment outcomes

• Published in: Jornal brasileiro de pneumologia 2022, Vol.48 (6), p.e20210505-e20210505
• Main Authors: Bezerra, André Luiz, Moreira, Adriana da Silva Rezende, Isidoro-Gonçalves, Lorrayne, Lara, Carla F Dos Santos, Amorim, Gustavo, Silva, Elisangela C, Kritski, Afrânio Lineu, Carvalho, Anna Cristina C
• Format: Article
• Language: English
• Subjects: Diabetes mellitus; Humans; Laboratories, Clinical; Longitudinal Studies; RESPIRATORY SYSTEM; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary - diagnostic imaging; Tuberculosis, Pulmonary - drug therapy; Tuberculosis/diagnosis; Tuberculosis/diagnostic imaging; Tuberculosis/therapy
• ISSN: 1806-3756; 1806-3756
• DOI: 10.36416/1806-3756/e20210505

To analyze the association of dysglycemia with clinical, laboratory, and radiographic characteristics of patients with pulmonary tuberculosis (PTB), as well as with their tuberculosis treatment outcomes. This was a longitudinal study involving 140 patients diagnosed with PTB (positive cultures for Mycobacterium tuberculosis or positive Xpert MTB/RIF results from sputum samples). Patients were evaluated at diagnosis (M0), after completing the second month of treatment (M2), and at the end of treatment (MEND). At M0, the patients were classified into three groups: normoglycemia+PTB (NGTB); pre-diabetes mellitus+PTB (PDMTB), and diabetes mellitus+PTB (DMTB), in accordance with glycated hemoglobin levels (< 5.7%, 5.7%-6.4%, and ≥ 6.5%, respectively). Treatment outcomes were classified as favorable (cure or treatment completion) and unfavorable (death, loss to follow-up, or treatment failure). In our sample, 76 patients (61.4%) had dysglycemia, 20 of whom (14.3%) had DM at M0. The patients with dysglycemia, in comparison with those in the NGTB group, more frequently presented with positive sputum smear microscopy (94.2% vs. 75.9%; p = 0.003); cavities (80.2% vs. 63.0%; p = 0.03); bilateral lesions (67.4% vs. 46.0%; p = 0.02); and higher median of affected thirds of the lungs (3.0 vs. 2.0; p = 0.03) on chest radiography. No significant differences regarding outcomes were found among the groups, but tuberculosis lethality was higher in the DMTB group than in the PDMTB and NGTB groups (20% vs. 2.2%). PTB patients with dysglycemia had laboratory and radiographic manifestations indicative of more advanced disease, and the risk of death was higher in the DMTB group. These findings reinforce the recommendation for early screening for DM in patients with newly diagnosed tuberculosis in order to reduce the risk of death during treatment.